data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Foghorn Therapeutics
(NASDAQ:FHTX)
13.92
00
At close: Jun 27
13.92
00
PreMarket: 4:02PM EDT
15 minutes delayed
Day High/Low- - -
52 Week High/Low8.01 - 24.34
Open / Close- / -
Float / Outstanding23.9M / 41.5M
Vol / Avg.- / 150.1K
Mkt Cap577.2M
P/E-
50d Avg. Price12.32
Div / Yield-
Payout Ratio-
EPS-0.65
Total Float23.9M

Foghorn Therapeutics (NASDAQ:FHTX), Quotes and News Summary

Foghorn Therapeutics (NASDAQ: FHTX)

Day High/Low- - -
52 Week High/Low8.01 - 24.34
Open / Close- / -
Float / Outstanding23.9M / 41.5M
Vol / Avg.- / 150.1K
Mkt Cap577.2M
P/E-
50d Avg. Price12.32
Div / Yield-
Payout Ratio-
EPS-0.65
Total Float23.9M
Benzinga - May 24, 2022, 8:39AM
Benzinga - May 23, 2022, 8:54AM
Benzinga - May 20, 2022, 9:03AM
Benzinga - May 20, 2022, 6:25AM
Benzinga - May 20, 2022, 6:19AM
Benzinga - May 19, 2022, 4:20PM
Benzinga - May 19, 2022, 4:18PM
Benzinga - May 19, 2022, 4:02PM
Benzinga - May 9, 2022, 7:12AM
Benzinga - Apr 13, 2022, 11:31AM
Benzinga - Mar 10, 2022, 7:22AM
Benzinga - Jan 20, 2022, 7:23AM
Benzinga - Dec 15, 2021, 9:27AM
Benzinga - Dec 13, 2021, 8:57AM
Benzinga - Dec 13, 2021, 8:00AM
load more
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-09
REV
Q1 2022Est.ActualSurprise
EPS-0.650
REV3.920M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Foghorn Therapeutics Questions & Answers

Q
How do I buy Foghorn Therapeutics (FHTX) stock?
A

You can purchase shares of Foghorn Therapeutics (NASDAQ: FHTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Foghorn Therapeutics's (FHTX) competitors?
A

There are no as such competitors for Foghorn Therapeutics.

Q
What is the target price for Foghorn Therapeutics (FHTX) stock?
A

The latest price target for Foghorn Therapeutics (NASDAQ: FHTX) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 21.00 expecting FHTX to rise to within 12 months (a possible 50.86% upside). 5 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Foghorn Therapeutics (FHTX)?
A

The stock price for Foghorn Therapeutics (NASDAQ: FHTX) is $13.92 last updated June 27, 2022, 8:00 PM UTC.

Q
Does Foghorn Therapeutics (FHTX) pay a dividend?
A

There are no upcoming dividends for Foghorn Therapeutics.

Q
When is Foghorn Therapeutics (NASDAQ:FHTX) reporting earnings?
A

Foghorn Therapeutics’s Q2 earnings are confirmed for Tuesday, August 9, 2022.

Q
Is Foghorn Therapeutics (FHTX) going to split?
A

There is no upcoming split for Foghorn Therapeutics.

Q
What sector and industry does Foghorn Therapeutics (FHTX) operate in?
A

Foghorn Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.